MET and neoplasm: OC possesses its activity through the disruption of c-Met related pathways as a prototypic member of a unique subfamily of receptor tyrosine kinases (RTKs) [17,18], while phosphorylated (activated) c-Met is considered an important predictor of tumor aggressiveness, poor survival, and metastatic potential, including TNBC [19].